Home Determination of H+/K+-ATPase Activity in Human Gastric Biopsy Specimens
Article
Licensed
Unlicensed Requires Authentication

Determination of H+/K+-ATPase Activity in Human Gastric Biopsy Specimens

  • István Kocsis , Barna Vásárhelyi , Zsolt Tulassay , Teréz Szabó , Ágota Vér and Tivadar Tulassay
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 38 Issue 8

Abstract

The aim of our work was to develop a method to determine the the H+/K+-ATPase activity of human gastric biopsy samples.

Our method is based on the phosphatase activity and the K+-induceable property of the enzyme. K+-induceable pNPPase activity was determined from homogenated corpus and antrum biopsy samples. H+/K+-ase activity was calculated as the difference between the corpus and antrum K+-induceable pNPPase activities.

Quality control measurements were done during 20 successive days from pooled homogenates. The total, between-day and between-run, within-day and within-run coefficients of variations were between 10 and 16%. The healthy mean and reference range of K+-induceable pNPPase activity in the corpus was 95.8 (95% CI: 83.4–108.2 mU/mg protein); in the antrum it was 28.3 (21.6–35.0) mU/mg protein. The calculated H+/K+-ATPase activity was 67.2 (56.9–77.5) mU/mg protein. The measured activities were independent of the age and gender.

Summarizing our results we have concluded, that our novel method might be a potential tool to gather data about the functional acid producing capability of human gastric mucosa.

:
Published Online: 2005-06-01
Published in Print: 2000-08-21

Copyright © 2000 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Changes of the Coagulation and Fibrinolysis System in Malignancy: Their possible Impact on Future Diagnostic and Therapeutic Procedures
  2. Laboratory Support of the Clinical Nutrition Service
  3. A new Method for Fast Haptoglobin Phenotyping and Hemoglobin Binding Capacity Calculation Based on Capillary Zone Electrophoresis
  4. Apolipoprotein E Polymorphism and Serum Concentration in Alzheimer's Disease in Nine European Centres: the ApoEurope Study
  5. Association of the Apolipoprotein B Gene Polymorphisms with Cholesterol Levels and Response to Fluvastatin in Brazilian Individuals with High Risk for Coronary Heart Disease
  6. Antioxidant Status, Erythrocyte Membrane Lipid Peroxidation and Osmotic Fragility in Malignant Lymphoma Patients
  7. Determination of H+/K+-ATPase Activity in Human Gastric Biopsy Specimens
  8. European Cerebrospinal Fluid Consensus Group a TeamRoom (Lotus Notes)-Based Communication Network
  9. Automated Enzymatic Mitochondrial Antibody Assay for the Diagnosis of Primary Biliary Cirrhosis
  10. Study of IgM Aggregation in Serum of Patients with Macroglobulinemia
  11. Trace Element Reference Values in Serum Determined by Inductively Coupled Plasma Atomic Emission Spectrometry
  12. Comparison of Two Different Methods for Measurement of Phenylalanine in Dried Blood Spots
  13. Anti-β2-Glycoprotein I ELISA: Methodology, Determination of Cut-off Values in 434 Healthy Caucasians and Evaluation of Monoclonal Antibodies as Possible International Standards
  14. Comparative Multicentre Study of a Panel of Thyroid Tests Using Different Automated Immunoassay Platforms and Specimens at High Risk of Antibody Interference
  15. A G5569A HFE Gene Polymorphism that Interferes in DNA Tests for Genetic Haemochromatosis: Who Needs to Be Re-tested?
  16. Evaluation of the Conformity of Human Growth Hormone. Concentrations Measured with the DPC Immulite® and the Nichols® Advantage™ Assays
  17. Atlas of Atherosclerosis – Progression and Regression. By Herbert C. Stary
  18. Liver Disease and Laboratory Medicine. By Ian McFarlane, Adrian Bomford and Roy Sherwood
Downloaded on 23.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2000.105/html?lang=en
Scroll to top button